Gut Microbiome

Researchers have developed a machine learning model using gut microbiome data sets for the diagnostic screening of CVD, according to findings presented at the American Heart Association Hypertension Scientific Sessions.

In newly issued guidelines, the American Gastroenterological Association did not recommend using probiotics for most digestive conditions.

A new microbiome-based treatment for Clostridioides difficile infection showed success in reducing recurrence of the infection at 8 weeks, according to preliminary results released by the manufacturer.

New data published in Hypertension have shown that a unique profile of gut bacteria can predict the presence of pulmonary artery hypertension in patients with 83% accuracy.

Patterns of microbiota disruption, marked by loss of intestinal diversity and single taxa domination, appeared similar among a cohort of patients undergoing allogeneic hematopoietic stem cell transplantation across various centers and geographic areas, according to findings published in The New England Journal of Medicine.

Healthy women with long-term changes in plasma trimethylamine N-oxide, a choline metabolite produced from gut microbiota, had an increased risk for CHD, which may be modified by healthy dietary patterns, according to a prospective nested case-control study published in the Journal of the American College of Cardiology.

Investigators have completed enrollment in a phase 3 trial set to investigate RBX2660, a therapy that uses the gut microbiota to treat Clostridioides difficile infection, according to a press release issued by Rebiotix, the manufacturer.

Gut microbiota analysis was cost-effective for predicting and possibly preventing 90-day readmissions for cirrhosis, according to study results.

In an ongoing effort to keep up with the rapidly expanding field of psychogastroenterology and the latest updates on research, science and clinical practice advocacy, Healio Gastroenterology and Liver Disease proudly presents “When in Rome: Gastro Psych Blog.” This new resource aims to give practicing physicians more insight into the scientific and clinical intersection of gastroenterology and psychology.

Adolescents with obesity and polycystic ovary syndrome have an altered gut microbiome compared with girls without PCOS with a similar BMI and dietary habits, according to findings from a case-control study.